Home / Pharma Healthcare / United States Recombinant Protein Market Report 2016

United States Recombinant Protein Market Report 2016

  • Id : RNR-17173
  • Category : Pharma Healthcare
  • Publish Date : 7-Oct
  • Pages : 124
  • Format : PDF
License Type

Description
Notes:
Sales, means the sales volume of Recombinant Protein
Revenue, means the sales value of Recombinant Protein

This report studies sales (consumption) of Recombinant Protein in United States market, focuses on the top players, with sales, price, revenue and market share for each player, covering
    Pfizer, Inc. (US)
    Bayer HealthCare Pharmaceuticals, Inc. (US)
    GlaxoSmithKline (UK)
    AbbVie, Inc. (US)
    Anavex Life Sciences Corp. (US)
    Baxter International, Inc. (US)
    Biocon (India)
    Eli Lilly (US)
    F. Hoffmann-La Roche Ltd. (Switzerland)
    Genentech (US)
    Janssen Biotech, Inc. (US)
    Kemwell Biopharma (India)
    Novartis (Switzerland)
    Sun Pharmaceutical Industries Ltd. (India)
    Sanofi S.A. (France)

Split by product types, with sales, revenue, price, market share and growth rate of each type, can be divided into
    Type I
    Type II
    Type III
Split by applications, this report focuses on sales, market share and growth rate of  Recombinant Protein in each application, can be divided into
    Application 1
    Application 2
    Application 3